Informações:
Falhas:
ID
21752
Descrição
Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00347971
Link
https://clinicaltrials.gov/show/NCT00347971
Palavras-chave
Versões (1)
- 27/04/2017 27/04/2017 -
Transferido a
27 de abril de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Lymphoma, Non-Hodgkin NCT00347971
Eligibility Lymphoma, Non-Hodgkin NCT00347971
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma, Non-Hodgkin NCT00347971
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
B-Cell Lymphoma CD20 positive
Item
diagnosis of cd20+ b-cell nhl
boolean
C0079731 (UMLS CUI [1,1])
C3888518 (UMLS CUI [1,2])
C3888518 (UMLS CUI [1,2])
Measurable Disease X-Ray Computed Tomography
Item
disease measurable by computed tomography (ct) scan
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,2])
Lymphoma, Non-Hodgkin | systemic therapy Quantity failed
Item
has failed at least one prior systemic therapy for nhl
boolean
C0024305 (UMLS CUI [1])
C1515119 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C1515119 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Liver function | Renal function
Item
adequate hepatic and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232804 (UMLS CUI [2])
Bone Marrow function
Item
adequate bone marrow function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0031843 (UMLS CUI [1,2])
Communicable Disease | Systemic disease
Item
presence of acute infection or other significant systemic illness
boolean
C0009450 (UMLS CUI [1])
C0442893 (UMLS CUI [2])
C0442893 (UMLS CUI [2])
White Blood Cell Count Peripheral blood
Item
white blood cell (wbc) count > 50,000/mm3 in peripheral blood
boolean
C0023508 (UMLS CUI [1,1])
C0229664 (UMLS CUI [1,2])
C0229664 (UMLS CUI [1,2])
Central Nervous System Involvement
Item
central nervous system involvement by malignancy
boolean
C4050309 (UMLS CUI [1])
Transplantation, Homologous | Transplantation, Autologous
Item
previous allogenic transplant or autotransplant within 6 months of enrollment
boolean
C0040739 (UMLS CUI [1])
C0040736 (UMLS CUI [2])
C0040736 (UMLS CUI [2])
Malignant Neoplasms
Item
other current malignancy or known history of cancer within 5 years
boolean
C0006826 (UMLS CUI [1])
CORTICOSTEROIDS FOR SYSTEMIC USE | Chemotherapy | Immunotherapy | Biological treatment | antibody therapy | rituximab | Therapeutic radiology procedure | Investigational New Drugs
Item
received systemic corticosteroids, chemotherapy, immunotherapy, biologic therapy, antibody therapy (e.g., rituximab), radiation therapy, and/or investigational agent(s) within 1 month of enrollment
boolean
C3653708 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0281176 (UMLS CUI [5])
C0393022 (UMLS CUI [6])
C1522449 (UMLS CUI [7])
C0013230 (UMLS CUI [8])
C0392920 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C1531518 (UMLS CUI [4])
C0281176 (UMLS CUI [5])
C0393022 (UMLS CUI [6])
C1522449 (UMLS CUI [7])
C0013230 (UMLS CUI [8])